Literature DB >> 2537404

Kinetics of chlorpromazine block of sodium channels in single guinea pig cardiac myocytes.

N Ogata1, M Nishimura, T Narahashi.   

Abstract

Block of sodium current by chlorpromazine in single ventricular myocytes isolated from guinea pigs was studied using the whole cell patch clamp technique. Chlorpromazine in micromolar concentrations reduced the amplitude of peak sodium current associated with step depolarizations from a holding potential of -140 mV. Concentration-response curves obtained with a holding potential of -140 mV were best fit by a 2:1 stoichiometry, and were shifted in the direction of lower concentrations when a holding potential of -100 mV was used. In agreement with this observation, the steady-state inactivation curve was shifted to more negative potentials by chlorpromazine. The block was not associated with any change in the time course of sodium current activation or inactivation during a depolarizing step. Chlorpromazine also produced marked use-dependent block as demonstrated by a cumulative increase in the block during a train of depolarizing pulses. This use dependence was due to a higher affinity of chlorpromazine for the inactivated state of sodium channels than for the resting state and to a very slow repriming of the drug-bound sodium channels from inactivation. These blocking actions could contribute to the antiarrhythmic effects of chlorpromazine at low concentrations and to the cardiotoxic effects at high concentrations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537404

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Sodium current kinetics in freshly isolated neostriatal neurones of the adult guinea pig.

Authors:  N Ogata; H Tatebayashi
Journal:  Pflugers Arch       Date:  1990-07       Impact factor: 3.657

2.  Block of sodium channels by psychotropic drugs in single guinea-pig cardiac myocytes.

Authors:  N Ogata; T Narahashi
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

3.  Chlorpromazine inhibits miniature GABAergic currents by reducing the binding and by increasing the unbinding rate of GABAA receptors.

Authors:  J W Mozrzymas; A Barberis; K Michalak; E Cherubini
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

4.  Neurotoxic activity of venom from the Australian eastern mouse spider (Missulena bradleyi) involves modulation of sodium channel gating.

Authors:  L D Rash; L C Birinyi-Strachan; G M Nicholson; W C Hodgson
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

5.  Differential block of sodium and calcium channels by chlorpromazine in mouse neuroblastoma cells.

Authors:  N Ogata; M Yoshii; T Narahashi
Journal:  J Physiol       Date:  1990-01       Impact factor: 5.182

6.  Modulation of sodium current kinetics by chlorpromazine in freshly-isolated striatal neurones of the adult guinea-pig.

Authors:  N Ogata; H Tatebayashi
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

7.  Differential inhibition of a transient K+ current by chlorpromazine and 4-aminopyridine in neurones of the rat dorsal root ganglia.

Authors:  N Ogata; H Tatebayashi
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Kinetic analysis of two types of Na+ channels in rat dorsal root ganglia.

Authors:  N Ogata; H Tatebayashi
Journal:  J Physiol       Date:  1993-07       Impact factor: 5.182

9.  Modification of sodium channel gating and kinetics by versutoxin from the Australian funnel-web spider Hadronyche versuta.

Authors:  G M Nicholson; M Willow; M E Howden; T Narahashi
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

10.  Impact of synaptic neurotransmitter concentration time course on the kinetics and pharmacological modulation of inhibitory synaptic currents.

Authors:  Andrea Barberis; Enrica Maria Petrini; Jerzy W Mozrzymas
Journal:  Front Cell Neurosci       Date:  2011-06-22       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.